Oral tobacco may slow MS progression more than smoking

A new study finds oral tobacco use is associated with slower disease progression in multiple sclerosis patients compared to smoking. The finding could reshape how clinicians counsel MS patients about nicotine use and has implications for tobacco harm-reduction strategies in neurological disease management.

Originaltitel: Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression